Management of hepatitis B in pregnancy: Weighing the options

Cleveland Clinic Journal of Medicine

Volumn 76, Issue SUPPL.3, 2009, Pages

  Tran, Tram T ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

ARTICLE; DISEASE TRANSMISSION; FEMALE; HEPATITIS B; HUMAN; PREGNANCY; PREGNANCY COMPLICATION; VIRUS LOAD;

ANTIVIRAL AGENTS; FEMALE; HEPATITIS B; HEPATITIS B, CHRONIC; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; VIRAL LOAD;

EID: 68049137781     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.76.s3.06     Document Type: Article

References (18)

1. Schrag SJ, Arnold KE, Mohle-Boetani JC, et al. Prenatal screening for infectious diseases and opportunities for prevention. Obstet Gynecol 2003; 102:753-760.
2. Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 2006; 28:112-125.
3. Mast EE, Weinbaum CM, Fiore AE, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep 2006; 55(RR-16):1-33.
4. Centers for Disease Control and Prevention (CDC). Implementation of newborn hepatitis B vaccination-worldwide, 2006. MMWR Morb Mortal Wkly Rep 2008; 57:1249-1252.
5. McMahon BJ, Alward WL, Hall DB, et al. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis 1985; 151:599-603.
6. Tassopoulos NC, Papaevangelou GJ, Sjogren MH, Roumeliotou-Karayannis A, Gerin JL, Purcell RH. Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults. Gastroenterology 1987; 92:1844-1850.
7. Chang MH. Natural history of hepatitis B virus infection in children. J Gastroenterol Hepatol 2000; 15(suppl):E16-E19.
8. Beasley RP, Trepo C, Stevens CE, Szmuness W. The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol 1977; 105:94-98.
9. Wong VC, Ip HM, Reesink HW, et al. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin: double-blind randomised placebocontrolled study. Lancet 1984; 1(8383):921-926.
10. Okada K, Kamiyama I, Inomata M, Imai M, Miyakawa Y. e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants. N Engl J Med 1976; 294:746-749.
11. Xu DZ, Yan YP, Choi BC, et al. Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case-control study. J Med Virol 2002; 67:20-26.
12. Burk RD, Hwang LY, Ho GY, Shafritz DA, Beasley RP. Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load. J Infect Dis 1994; 170:1418-1423.
13. Wiseman E, Fraser MA, Holden S, et al. Perinatal transmission of hepatitis B virus: viral load and HBeAg status are significant risk factors. Presented at: 59th Annual Meeting of the American Association for the Study of Liver Diseases; October 31-November 4, 2008; San Francisco, CA. Abstract 827.
14. Pande C, Kumar A, Patra S, Trivedi SS, Dutta AK, Sarin SK. High maternal hepatitis B virus DNA levels but not HBeAg positivity predicts perinatal transmission of hepatitis B to the newborn. Presented at: Digestive Disease Week; May 17-22, 2008; San Diego, CA. Abstract 252.
15. van Zonneveld M, van Nunen AB, Niesters HG, de Man RA, Schalm SW, Janssen HL. Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection. J Viral Hepat 2003; 10:294-297.
16. Xu W-M, Cui Y-T, Wang L, et al. Efficacy and safety of lamivudine in late pregnancy for the prevention of mother-child transmission of hepatitis B: a multicentre, randomised, double-blind, placebocontrolled study [AASLD abstract 246]. Hepatology 2004; 40:272A.
17. Antiretroviral Pregnancy Registry Steering Committee. Antiretroviral pregnancy registry international interim report for 1 January 1989 through 31 July 2008. Wilmington, NC: Registry Coordinating Center; 2008. Antiretroviral Pregnancy Registry Web site. http:// www.apregistry.com/forms/interim_report.pdf. Accessed December 17, 2008.
18. Tran TT, Keeffe EB. Management of the pregnant hepatitis B patient. Current Hepatitis Reports 2008; 7:12-17.